Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-937

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

FDA Label Image

Cyclophosphamide Intalere Choice Representative Container Lbl 10019-935-25 (Image 02)

This text is a product label for Cyclophosphamide, a medication that is available in a vial containing 500mg. The medication is administered through intravenous infusion by adding 25 mL. It is recommended to use only sterile, non-pyrogenic Sodium Chloride Injection, USP for single-dose use. The vial should be stored at or below 25°C (77°F). The label also mentions to refer to the Insert for Indications and dosage schedule before use. The product is manufactured by Baxter Healthcare Corporation, located in Deerfed, IL, USA and made in Germany.*

FDA Label Image

Representative Cyclophosphamide Intalere Ndc 10019-935-01 Panel 1 (Image 03)

This is a medication label for Cyclophosphamide for Injection, USP. It comes in a single dose vial with 500 mg of the drug, which must be diluted for IV infusion or direct injection use. The vial should be stored at or below 25°C. The label provides instructions for IV infusion or direct injection use, including adding either 25 ml of sterile water for injection or 25 mL of 0.9% Sodium Chloride injection, and shaking vigorously to dissolve the drug. It contains important warnings about dosage, indications, and toxicity. This is a cytotoxic agent and is intended for single dose use, for parenteral use, sterile and non-pyrogenic. This medication is manufactured in Germany by Baxter Healthcare Corporation based in Deerfield, IL 60015 USA, and its control number is NDC 10019-935-01.*

FDA Label Image

Z:\ni\sgl_spl_2018\cyclophosphamide Anda 040745 Intalere Pkging Update Vv 06042018\ha-80-02-316_panel 2.jpgrepresentative Cyclophosphamide Intalere Ndc 10019-935-01 Panel 2 (Image 04)

This is a product description of Cyclophosphamide injection: a prescription medicine used to treat cancer. It comes in 500 mg/vial concentration and must be diluted for IV infusion or direct injection use. The medication is manufactured for Intalere Choice by Baxter Healthcare Corporation in Germany. The NDC codes for the drug are provided as 10018-035-01 and 10019-935-01.*

FDA Label Image

Cyclophosphamide Intalere Choice Representative Container Lbl 10019-936-60 (Image 05)

This is a medication called Cyclophosphamide. Each vial contains 1 g of the drug, and it can be administered via IV infusion or direct injection for single-use. For IV infusion, 50 mL of Sterile Water for Injection, USP, needs to be added and shaken vigorously to dissolve the drug. For direct injection, 50 mL of only 0.9% Sodium Chloride Injection, USP, is required to dissolve the drug. It is a cytotoxic agent, and the insert should be checked for indications and dosage. The medication needs to be stored at or below 25°C (77°F). The manufacturer is Boter Heatihare CorporaionDerfd in Germany, manufactured for Intalere Choice in the USA.*

FDA Label Image

Cyclophosphamide Intalere Representative Carton Lbl 10019-936-01 Panel 1 (Image 06)

This is a description of a medication called "Cyclophosphamide". It is a cytotoxic agent that comes in a single-use vial of 1 gram/vial for injection. It must be diluted for IV infusion or direct injection use. To use it, 50 mL of Sterle Water for Injection or 0.9% Sodium Chioride Injection must be added to dissolve the drug. The vials should be stored at or below 25°C (77°F). It is important to read the accompanying literature for directions for use, dose, indications and toxicity. This medication is sterile and non-pyrogenic and manufactured by Baxter Healthcare Corporation in Germany for Intalere Choice.*

FDA Label Image

Cyclophosphamide Intalere Representative Carton Lbl 10019-936-01 Panel 2 (Image 07)

Cyclophosphamide for Injection is a medication that comes in a 1-gram vial, requiring dilution for IV infusion or direct injection. The medication is manufactured by Baxter HealthCare Corporation under the Intalere Choice brand in Germany. The medication has an NDC number of 10019-936-01 or 10019-036-01.*

FDA Label Image

Cyclophosphamide Intalere Representative Container Lbl 10019-937-10 (Image 08)

FDA Label Image

Representative Cyclophosphamide Intelere Carton Lbl Ndc 10019-937-01 Panel 1 (Image 09)

This is a description of a Cyclophosphamide drug, which comes in a single dose vial containing 2 grams of the drug. The drug should be diluted before use, either for IV infusion or direct injection use, and comes with accompanying literature that must be read thoroughly before use. The drug is a cytotoxic agent and is for single-dose use only. It is sterile and non-pyrogenic, and should only be used for parenteral use. It is manufactured for Intalere Choice by Baxter Healthcare Corporation in Deerfield, IL, USA and is made in Germany. Storage instructions are included, and the vial must be stored at or below 25°C (77°F) [see USP Controlled Room Temperature].*

FDA Label Image

Representative Cyclophosphamide Intelere Carton Lbl Ndc 10019-937-01 Panel 2 (Image 10)

This text refers to two vials of Cyclophosphamide for Injection, USP with 2 grams each that must be diluted for IV infusion or direct injection use. The product is manufactured by Baxter Healthcare Corporation and its single-dose vials are approved by Intalere and Alere. There is also information about the product's NDC number, the manufacturing location, and a Lot number.*

FDA Label Image

Representative Shipper Label 10019-935-01 (Image 11)

Cyclophosphamide for Injection, USP is available in 500mg single dose vials, with each pack containing 120 vials. The product should be stored at or below 25°C (77°F) and has an INDC number of 10019-935-01. The vials have an expiry date of MMM JJJJ and LOT number of JMXXXA. The quantity of each pack is 00.*

FDA Label Image

Representative Shipper Label 10019-936-01 (Image 12)

This is a product description of "Intalere Choice" which includes "Cyclophosphamide for Injection, USP 1 g". The solution comes in 1 gram single dose vials and is manufactured by Baxter Healthcare Corporation in the US. The product should be stored at or below 25°C (77°F). The label also includes an expiration date (MMM JJJJ) and LOT number (JMXXXA) with corresponding quantities (QTY: 00). There are some numbers in parentheses that cannot be understood, and a barcode printed on the label.*

FDA Label Image

Representative Shipper Label 10019-937-01 (Image 13)

This is a description of a medication called Cyclophosphamide for Injection, USP 2 g, manufactured for Intalere Choice by Baxter Healthcare Corporation. The medication comes in 60 packs with each pack containing 1 x 2 g single dose vials. The medication should be stored at or below 25°C (77°F). The label also includes a lot number (JMXXXA) and an expiry date (MMM JJJJ).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.